Envoy Medical (COCH) director reports 25,000 new stock options at $0.813

Rhea-AI Filing Summary

Envoy Medical, Inc. director Mona Chetan Patel reported changes in her holdings on a Form 4. On 12/03/2025 she acquired 25,000 stock options, each with an exercise price of $0.813, exercisable starting 05/01/2026 and expiring 12/03/2035, covering 25,000 shares of Class A common stock. She also beneficially owns 20,000 shares of Class A common stock directly and holds 25,000 stock options with a $2.4 exercise price expiring 10/15/2033. The filing notes that options to purchase 6,250 shares vest on 10/15/2024, with the remaining 18,750 shares vesting pro rata on the 15th of each month for 36 months.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Patel Mona Chetan

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	25,000	$0.00	--
holding	Stock Option (right to buy)	--	--	--
holding	Class A Common Stock	--	--	--

Holdings After Transaction: Stock Option (right to buy) — 25,000 shares (Direct); Class A Common Stock — 20,000 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Patel Mona Chetan

(Last) (First) (Middle)

C/O 4875 WHITE BEAR PARKWAY

(Street)

WHITE BEAR LAKE MN 55110

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Envoy Medical, Inc. [ COCH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock								20,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$2.4							(1)	10/15/2033	Class A Common Stock	25,000		25,000	D
Stock Option (right to buy)	$0.813	12/03/2025		A		25,000		05/01/2026	12/03/2035	Class A Common Stock	25,000	$0	25,000	D

Explanation of Responses:

1. Options to purchase 6,250 shares vest on 10/15/2024, and the remaining 18,750 shares vest pro rata on the 15th of each month thereafter for 36 consecutive months.

	/s/ Andrew Nick as Attorney-in-Fact for Mona Chetan Patel pursuant to Power of Attorney previously filed.	12/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Envoy Medical (COCH) disclose in this Form 4 filing?

The filing reports that director Mona Chetan Patel changed her beneficial ownership in Envoy Medical, Inc. On 12/03/2025 she acquired 25,000 stock options with an exercise price of $0.813 per share and updated her reported stock and option holdings.

How many Envoy Medical stock options were acquired and at what price?

On 12/03/2025 the director acquired 25,000 stock options (stock options, right to buy) with an exercise price of $0.813 per share. These options cover 25,000 shares of Envoy Medical Class A common stock and are reported with a derivative security price of $0.

What is the vesting schedule described for Envoy Medical stock options?

The filing explains that options to purchase 6,250 shares vest on 10/15/2024, and the remaining 18,750 shares vest pro rata on the 15th of each month for 36 consecutive months, for a total of 25,000 option shares under that vesting schedule.

How many Envoy Medical shares and options does the director beneficially own after the reported transactions?

After the reported transactions, the director beneficially owns 20,000 shares of Envoy Medical Class A common stock directly. She also holds 25,000 stock options with an exercise price of $2.4 expiring on 10/15/2033 and 25,000 stock options with an exercise price of $0.813 expiring on 12/03/2035.

What is the reporting person’s relationship to Envoy Medical?

The reporting person is identified as a Director of Envoy Medical, Inc. The form is indicated as filed by one reporting person, and the signature is provided by an attorney-in-fact acting for Mona Chetan Patel.